Press release
Adrenocorticotropic Hormone (ACTH) Market Outlook 2031: From US$ 1.3 Billion in 2020 to Significant Growth by 2031, Driven by Rising Endocrine Disorders and Diagnostic Advancements
Adrenocorticotropic Hormone (ACTH) Market
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76241
Market Overview
The ACTH Market encompasses ACTH-based products used for diagnostic testing (e.g., ACTH stimulation tests) and therapeutic applications for adrenal insufficiency and related disorders. Valued at US$ 1.3 billion in 2020, the market is expected to grow at a CAGR of 3.9% through 2031. It is segmented by product type (natural, synthetic), application (diagnostic, therapeutic), indication (adrenal insufficiency, Cushing's syndrome, others), distribution channel (hospital pharmacies, retail pharmacies, online), end-user (hospitals, clinics, diagnostic laboratories), and region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa). Diagnostic applications dominate due to widespread use in adrenal function testing, while hospitals lead as end-users.
Key Drivers of Growth
Several factors are propelling the growth of the ACTH Market:
Rising Prevalence of Endocrine Disorders: Increasing cases of adrenal insufficiency, Cushing's syndrome, and other hormonal disorders drive demand for ACTH-based diagnostics and treatments.
Advancements in Diagnostic Tools: Improved ACTH stimulation tests and biomarker-based diagnostics enhance accuracy in detecting adrenal disorders, boosting market adoption.
Growing Aging Population: The global aging demographic increases the incidence of endocrine disorders, necessitating ACTH-based interventions.
Supportive Regulatory Approvals: Regulatory approvals for synthetic ACTH formulations and diagnostic kits by agencies like the FDA and EMA facilitate market growth.
Increasing Healthcare Investments: Rising investments in endocrine care and diagnostic infrastructure, particularly in developed regions, support market expansion.
Top Companies:
Pfizer, Inc.
Astellas Pharma, Inc.
Novartis AG
F. Hoffmann-La Roche Ltd.
Sanofi
Bristol-Myers Squibb Company
GlaxoSmithKline plc
AbbVie, Inc.
Hansa Biopharma
WOCKHARDT
Viatris, Inc.
Glenmark
Biocon
Hikma Pharmaceuticals plc
Teva Pharmaceutical U.S.A Inc.
Zydus Pharmaceuticals, Inc.
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/adrenocorticotropic-hormone-market.html
Challenges and Barriers
Despite its growth potential, the market faces several challenges:
High Treatment Costs: ACTH therapies, particularly for rare disorders, are expensive, limiting accessibility for patients in low-income regions.
Limited Awareness in Developing Regions: Low awareness of adrenal disorders and ACTH-based treatments in Africa and parts of Asia-Pacific restricts market penetration.
Regulatory Complexities: Stringent regulations for hormone-based therapies and diagnostics increase compliance costs and delay market entry.
Side Effects and Safety Concerns: Potential side effects of ACTH therapies, such as hypertension or immune suppression, may reduce patient compliance.
Competition from Alternative Diagnostics: Emerging non-hormonal diagnostic methods for adrenal disorders could limit reliance on ACTH-based tests.
Regional Insights
The ACTH Market exhibits distinct regional dynamics:
North America: North America dominates, driven by advanced healthcare systems, high prevalence of endocrine disorders, and robust diagnostic infrastructure. The U.S. leads due to strong R&D and regulatory support.
Europe: Europe is a key market, with Germany, France, and the UK benefiting from well-established healthcare systems and increasing diagnosis rates.
Asia-Pacific: Asia-Pacific is expected to witness rapid growth, fueled by rising healthcare expenditure, growing endocrine disorder prevalence, and improving diagnostic access in China, India, and Japan.
Latin America: Latin America shows moderate growth, with Brazil and Mexico leading due to expanding healthcare infrastructure. Limited awareness slows progress in smaller markets.
Middle East & Africa: This region has the smallest share due to limited healthcare access and awareness. Growth opportunities exist in Gulf countries with rising investments.
Future Opportunities
The ACTH Market offers several avenues for growth and innovation:
Development of Synthetic ACTH: Advances in synthetic ACTH formulations with improved stability and fewer side effects could drive market demand.
Expansion in Emerging Markets: Increasing healthcare investments in Asia-Pacific and Latin America present opportunities for affordable ACTH solutions.
Precision Diagnostics: Integrating ACTH tests with advanced biomarkers and imaging could enhance diagnostic accuracy and market growth.
Patient Education Programs: Awareness campaigns in underserved regions could increase diagnosis rates and treatment uptake.
Partnerships with Diagnostic Labs: Collaborations with laboratories and healthcare providers can streamline ACTH test and therapy access, boosting market reach.
Browse More Trending Research Reports:
Liquid Filled Hard Capsules Market: https://www.globenewswire.com/news-release/2023/7/4/2699010/0/en/Liquid-Filled-Hard-Capsules-Market-to-Grow-at-a-CAGR-of-7-8-from-2022-to-2031-reaching-US-4-0-billion-As-per-TMR-Study.html
Oral Rehydration Solution [ORS] Market: https://www.globenewswire.com/news-release/2023/10/05/2755222/32656/en/Oral-Rehydration-Solution-ORS-Market-to-Exceed-USD-6-71-billion-by-2031-Capturing-a-9-9-CAGR-TMR-Report.html
Atopic Dermatitis Drugs Market: https://www.globenewswire.com/news-release/2023/07/31/2715115/32656/en/Atopic-Dermatitis-Drugs-Market-to-Grow-at-a-CAGR-of-14-7-from-2022-to-2031-reaching-USD-29-4-Billion-As-per-TMR-Study.html
Oligonucleotides Market: https://www.globenewswire.com/news-release/2024/12/02/2989923/32656/en/Oligonucleotides-Market-Outlook-2034-Projected-to-Reach-US-13-1-Billion-by-2034-Driven-by-Expanding-Applications-in-Biotechnology-and-Precision-Medicine-TMR.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adrenocorticotropic Hormone (ACTH) Market Outlook 2031: From US$ 1.3 Billion in 2020 to Significant Growth by 2031, Driven by Rising Endocrine Disorders and Diagnostic Advancements here
News-ID: 4087753 • Views: …
More Releases from Transparency Market Research
A2P SMS Market Outlook 2035: Expanding from US$ 71.2 Bn in 2024 to US$ 117.0 Bn …
The global Application-to-Person (A2P) SMS market is entering a phase of steady and resilient expansion, driven by the growing need for secure, reliable, and real-time communication between enterprises and consumers. Valued at US$ 71.2 Bn in 2024, the market is projected to reach US$ 117.0 Bn by 2035, expanding at a CAGR of 4.2% from 2025 to 2035. Despite the rise of internet-based messaging platforms, A2P SMS continues to maintain…
Global Methanol Market to Reach USD 32.9 Billion by 2034, Growing at 3.4% CAGR | …
The global methanol market was valued at US$ 22.0 billion in 2023 and is expected to witness steady expansion over the next decade. According to industry analysis, the market is projected to grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2034, reaching an estimated US$ 32.9 billion by the end of 2034. This growth trajectory reflects the increasing relevance of methanol as a versatile chemical…
Methanol-to-Olefins Market Poised for Sustainable Growth, Set to Reach USD 44.1 …
The global Methanol-to-Olefins (MTO) market is witnessing a strong transformation as industries increasingly shift toward sustainable feedstocks and alternative non-petroleum chemical pathways. Valued at US$ 24.5 billion in 2023, the market is projected to expand at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2034, reaching an estimated US$ 44.1 billion by the end of 2034. This growth trajectory highlights the strategic importance of MTO technology in…
Global Methyl Chloride Market Outlook 2035: Expanding Silicone Demand and Indust …
The global methyl chloride market was valued at US$ 2.2 billion in 2023 and is poised for steady expansion over the coming decade. According to the latest industry outlook, the market is projected to grow at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2035, reaching an estimated US$ 4.1 billion by the end of 2035. This sustained growth reflects the compound's critical role as a chemical…
More Releases for ACTH
ACTH ELISA Test Kit Market Key Players, Share and Forecast Outlook
"The global market for ACTH ELISA test kits is valued at approximately $150 million in 2024, with a projected value of around $280 million by 2034. This represents a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period from 2025 to 2034. "
Exactitude Consultancy., Ltd. released a research report titled "ACTH ELISA Test Kit Market". This report covers the global ACTH ELISA Test Kit market sales, sales…
Innovative Horizons in the ACTH (1-39) Market: Trends and Leading Players
In today's dynamic global economy, the ACTH (1-39) market is emerging as a beacon of opportunity and innovation. With rapid technological advancements, evolving consumer demands, and proactive government policies shaping the landscape, this sector is setting the stage for transformative change. Our in-depth analysis delves into historical market trends, current dynamics, and future projections, providing industry leaders, investors, and decision-makers with the strategic insights needed to navigate this competitive terrain.
𝐆𝐞𝐭…
ACTH Deficiency Market is growing at a healthy CAGR 7.00% by 2028
Global ACTH Deficiency market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR 7.00% in the above-mentioned research forecast period. Rising prevalence of rare disorders such as Addison Disease, Gigantism, Cushing Syndrome, Childhood Obesity and others are the factors responsible for the growth of this market.
However, a rising population with unhealthy lifestyles…
Adrenocorticotropic Hormone [ACTH] Market to Record an Exponential CAGR by 2031
Adrenocorticotropic Hormone (ACTH) Market: Introduction
According to the report, the global adrenocorticotropic hormone (ACTH) market was valued at US$ 1.3 Bn in 2020 and is projected to expand at a CAGR of 3.9% from 2021 to 2031. Need for the development of newer and technologically enhanced products is rising globally, owing to treatment efficiency of drugs. Hence, major players operating in the market invest in research & development in order to develop new drugs. The rise in…
Adrenocorticotropic Hormone (ACTH) Market 2022: Mallinckrodt, Pfizer, Novartis A …
Adrenocorticotropic Hormone (ACTH) Market research report studies the competitive development of the market, such as agreements, new product launches, expansions, and acquisitions in the market. In addition, it provides a region-wise study of the market, including North America, Asia Pacific, Latin America, the Middle East, Africa, and Europe. As a result, it helps stakeholders understand market players and analyze the top 25 organizations based on their product footprint, market strength,…
ACTH Deficiency Treatment Market Analysis & Key Business Strategies by Leading I …
Adenocorticotropic hormone (ACTH) is produced and secreted by anterior pituitary gland. It is also called corticotropin, serum ACTH, etc. The hormone’s function is to regulate the levels of steroid hormone cortisol which is regulated by adrenal gland. ACTH is associated with diseases such as pituitary tumors and adrenal malfunctions. Deficiency of ACTH arises due to the absence or decreased production of adrenocorticotropic hormone, which leads to adrenal insufficiency. This results…
